Topical Timolol: a Comparison of Surgical Outcomes

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The use of topical beta-blockers, such as 0.25% timolol, in promoting wound healing is currently emerging in the literature. The investigators will enroll 30 participants in a split scar study who have their skin cancer surgically removed resulting in a linear wound equal to or longer than 4cm. The objective of this randomized study is to determine the safety and efficacy of 0.25% timolol in promoting wound healing in wound closed primarily greater than or equal to 1.5 cm.
Epistemonikos ID: 0b78813e9426353f90bdbf600a5c5894e7f19dc7
First added on: May 09, 2024